X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Part D Continues to Hold Down Costs, Maintain High Level of Patient Satisfaction

By Allyson Funk  |    August 28, 2014
Yesterday, the latest Congressional Budget Office (CBO) report was released examining projected long-term federal spending, including that of Medicare. Estimated Medicare spending will be...   Read More

ICYMI: Coverage of expensive drugs tops patients’ concerns

By Allyson Funk  |    August 18, 2014
A new story from the AP today, “Patient advocates say insurers avoiding the sick,” highlights the growing concern among patients and insurance commissioners about high cost-sharing for medicines in...   Read More

Second Annual PhRMA Survey: How Americans View Their Health, Three Important New Health Trends to Watch

By PhRMA Staff  |    August 13, 2014
This week we released From Hope to Cures: PhRMA’s Second Annual National Health Survey revealing new data on how Americans view their own health as well as that of the Nation. The survey also reveals...   Read More

Medicare Part D Continues to Be A Success

By Allyson Funk  |    August 4, 2014
Medicare Part D continues to be a success for beneficiaries. A new report released last week by the Congressional Budget Office (CBO), noted that Part D spending in 2013 was nearly 50 percent less...   Read More

Biopharmaceutical Research Companies Developing 92 Medicines to Treat Arthritis and Musculoskeletal Diseases

By Robert Zirkelbach  |    August 4, 2014
A Conversation on Continuing to Improve the Lives of Patients Living with Arthritis For many patients, hope for a brighter future is directly tied to the potential of medicines in the pipeline to...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates